Reneo Pharmaceuticals Inc

NASDAQ:RPHM   12:34:11 AM EDT
5.71
0.00 (0.00%)
Products

Reneo Pharmaceuticals Receives Fast Track Designation From The FDA For Mavodelpar

Published: 01/31/2023 14:16 GMT
Reneo Pharmaceuticals Inc (RPHM) - Reneo Pharmaceuticals Receives Fast Track Designation From the FDA for Mavodelpar (ren001) in a Genotype of Long-chain Fatty Acid Oxidation Disorder (lc-faod).
Reneo Pharmaceuticals Inc - Expects Topline Data From Stride Study in Q4 of This Year.